{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:08:34Z","timestamp":1784077714428,"version":"3.55.0"},"reference-count":33,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL148527"],"award-info":[{"award-number":["K23HL148527"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL163313"],"award-info":[{"award-number":["K23HL163313"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32HL007534"],"award-info":[{"award-number":["T32HL007534"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2024,5,27]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Given the heterogeneity of sarcoidosis, predicting disease course of patients remains a challenge. Our aim was to determine whether the 3-year change in pulmonary function differed between pulmonary function phenotypes and whether there were differential longitudinal changes by race and sex.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We identified individuals seen between 2005 and 2015 with a confirmed diagnosis of sarcoidosis who had at least two pulmonary function test measurements within 3 years of entry into the cohort. For each individual, spirometry, diffusion capacity, Charlson Comorbidity Index, sarcoidosis organ involvement, diagnosis duration, tobacco use, race, sex, age and medications were recorded. We compared changes in pulmonary function by type of pulmonary function phenotype and for demographic groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>\nOf 291 individuals, 59% (173) were female and 54% (156) were black. Individuals with restrictive pulmonary function phenotype had significantly greater 3-year rate of decline of FVC% (forced vital capacity) predicted and FEV\n<jats:sub>1<\/jats:sub>\n% (forced expiratory volume in 1 s) predicted course when compared with normal phenotype. We identified a subset of individuals in the cohort, highest decliners, who had a median 3-year FVC decline of 156 mL. Black individuals had worse pulmonary function at entry into the cohort measured by FVC% predicted, FEV\n<jats:sub>1<\/jats:sub>\n% predicted and diffusing capacity for carbon monoxide % predicted compared with white individuals. Black individuals\u2019 pulmonary function remained stable or declined over time, whereas white individuals\u2019 pulmonary function improved over time. There were no sex differences in rate of change in any pulmonary function parameters.\n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Summary<\/jats:title>\n<jats:p>We found significant differences in 3-year change in pulmonary function among pulmonary function phenotypes and races, but no difference between sexes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1136\/thorax-2023-221309","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:22:38Z","timestamp":1718990558000},"page":"1033-1039","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Pulmonary sarcoidosis: differences in lung function change over time"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1552-2579","authenticated-orcid":false,"given":"Michelle","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Psoter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy W","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha A","family":"Gilotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith C","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"2024101604001465000_79.11.1033.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST"},{"key":"2024101604001465000_79.11.1033.2","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-01993-z","article-title":"Clinical Phenotyping in Sarcoidosis using cluster analysis","volume":"23","author":"Lin","year":"2022","journal-title":"Respir Res"},{"key":"2024101604001465000_79.11.1033.3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of Bronchoalveolar Lavage cells identifies new molecular Endotypes of Sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur Respir J"},{"key":"2024101604001465000_79.11.1033.4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in Sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J"},{"key":"2024101604001465000_79.11.1033.5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.hrtlng.2022.06.020","article-title":"Sarcoidosis. Disease progression based on radiological and functional course: predictive factors","volume":"56","author":"Casal","year":"2022","journal-title":"Heart & Lung"},{"key":"2024101604001465000_79.11.1033.6","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.14d02.x"},{"key":"2024101604001465000_79.11.1033.7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.202204-328OC","article-title":"Heterogeneity of lung function phenotypes in Sarcoidosis: role of race and sex differences","volume":"20","author":"Sharp","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2024101604001465000_79.11.1033.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-020-01191-x","article-title":"Clinical characteristics and organ system involvement in Sarcoidosis: comparison of the University of Minnesota cohort with other cohorts","volume":"20","author":"Te","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024101604001465000_79.11.1033.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00166809"},{"key":"2024101604001465000_79.11.1033.10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of Sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"2024101604001465000_79.11.1033.11","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.171.3.2717731"},{"key":"2024101604001465000_79.11.1033.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00070503"},{"key":"2024101604001465000_79.11.1033.13","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201503-172OT"},{"key":"2024101604001465000_79.11.1033.14","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1183\/20734735.012717","article-title":"The global lung function initiative (GLI) network: bringing the world\u2019s respiratory reference values together","volume":"13","author":"Cooper","year":"2017","journal-title":"Breathe (Sheff)"},{"key":"2024101604001465000_79.11.1033.15","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.chest.2021.08.053","article-title":"Addressing race in pulmonary function testing by aligning intent and evidence with practice and perception","volume":"161","author":"Bhakta","year":"2022","journal-title":"Chest"},{"key":"2024101604001465000_79.11.1033.16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","article-title":"Clinical phenotypes in Sarcoidosis","volume":"20","author":"Pereira","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2024101604001465000_79.11.1033.17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.46497\/ArchRheumatol.2020.7584","article-title":"Sarcoidosis in Jordan: a study of the clinical phenotype and disease outcome","volume":"35","author":"Alnaimat","year":"2020","journal-title":"Arch Rheumatol"},{"key":"2024101604001465000_79.11.1033.18","first-page":"130","article-title":"Optimal scoring of serial change on chest radiography in Sarcoidosis","volume":"28","author":"Zappala","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101604001465000_79.11.1033.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025212"},{"key":"2024101604001465000_79.11.1033.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1876"},{"key":"2024101604001465000_79.11.1033.21","doi-asserted-by":"crossref","first-page":"106622","DOI":"10.1016\/j.rmed.2021.106622","article-title":"Patterns of medication use and imaging following initial diagnosis of Sarcoidosis","volume":"189","author":"Simmering","year":"2021","journal-title":"Respiratory Medicine"},{"key":"2024101604001465000_79.11.1033.22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028150","article-title":"Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies","volume":"9","author":"Thomas","year":"2019","journal-title":"BMJ Open"},{"key":"2024101604001465000_79.11.1033.23","first-page":"119","article-title":"The clinical course of Sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101604001465000_79.11.1033.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2013.06.005"},{"key":"2024101604001465000_79.11.1033.25","doi-asserted-by":"crossref","DOI":"10.1289\/EHP8584","article-title":"Disparities in air pollution exposure in the United States by race\/Ethnicity and income, 1990-2010","volume":"129","author":"Liu","year":"2021","journal-title":"Environ Health Perspect"},{"key":"2024101604001465000_79.11.1033.26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2021.05.006","article-title":"Air pollution and lung function in children","volume":"148","author":"Garcia","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2024101604001465000_79.11.1033.27","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.1.9001300"},{"key":"2024101604001465000_79.11.1033.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-7063-z","article-title":"Correlation between indoor air pollution and adult respiratory health in Zunyi city in Southwest China: situation in two different seasons","volume":"19","author":"Li","year":"2019","journal-title":"BMC Public Health"},{"key":"2024101604001465000_79.11.1033.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00130014"},{"key":"2024101604001465000_79.11.1033.30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000684","article-title":"Ambient air pollution, lung function and COPD: cross-sectional analysis from the WHO study of ageing and adult health wave 1","volume":"7","author":"Elbarbary","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"2024101604001465000_79.11.1033.31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.chest.2020.01.026","article-title":"Association of medication adherence and clinical outcomes in Sarcoidosis","volume":"158","author":"Sharp","year":"2020","journal-title":"Chest"},{"key":"2024101604001465000_79.11.1033.32","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cardfail.2023.03.022","article-title":"Sex and race differences in cardiac Sarcoidosis presentation","volume":"29","author":"Duvall","year":"2023","journal-title":"J Card Fail"},{"key":"2024101604001465000_79.11.1033.33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1590\/S1806-37132013000500003","article-title":"Delayed diagnosis of Sarcoidosis is common in Brazil","volume":"39","author":"Rodrigues","year":"2013","journal-title":"J Bras Pneumol"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-221309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T18:23:40Z","timestamp":1729103020000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-221309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,10,16]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/thorax-2023-221309"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-221309","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]}}}